The European Commission on Wednesday authorized the CCP virus vaccine developed by U.S. company Moderna, the second COVID-19 jab approved by the EU.
“With the Moderna vaccine, the second one now authorized in the EU, we will have a further 160 million doses. And more vaccines will come.”
Von der Leyen said the EU had secured up to 2 billion doses of potential COVID-19 vaccines, “more than enough” for the whole population of the 27-nation bloc.
The European Commission signed a contract with Moderna on Nov. 25 to deliver 160 million doses between the first and the third quarters of 2021.
These will add to the 300 million doses of the Pfizer/BioNTech vaccine, which the EU approved on Dec. 21.
The EMA has given a “conditional marketing authorization” for both, rather than the ultra-fast emergency use clearance issued by Britain, which the EU regulator says requires more detailed study of the data.
It has to be stored and shipped frozen, but does not require the ultra-cold temperatures of the Pfizer/BioNTech vaccine. Once thawed, it can be kept at typical refrigerator temperatures.
EU countries started vaccinations on Dec. 27 and are trying to catch up with countries such as Britain and Israel where large numbers of people have already received inoculations.